LIVER UCM
Fisiopatología hepática
Publicaciones (58) Publicaciones en las que ha participado algún/a investigador/a
2024
-
Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1
JHEP Reports, Vol. 6, Núm. 1
-
Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
Gut Microbes, Vol. 16, Núm. 1
-
Cirrhosis-downregulated LSECtin can be retrieved by cytokines, shifts the TLR-induced LSECs secretome and correlates with the hepatic Th response
Liver International, Vol. 44, Núm. 4, pp. 996-1010
-
Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network
Journal of Hepatology
-
Curcumin encapsulated in milk small extracellular vesicles as a nanotherapeutic alternative in experimental chronic liver disease
Biomedicine and Pharmacotherapy, Vol. 173
-
Fecal microbiota transplantation from female donors restores gut permeability and reduces liver injury and inflammation in middle-aged male mice exposed to alcohol
Frontiers in Nutrition, Vol. 11
-
Inhibition of ALK3-mediated signalling pathway protects against acetaminophen-induced liver injury
Redox Biology, Vol. 71
-
Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)
Gastroenterologia y Hepatologia
-
Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet
Pharmacological Research, Vol. 200
-
Seladelpar: New hope for patients with primary biliary cholangitis
Med
-
p63 controls metabolic activation of hepatic stellate cells and fibrosis via an HER2-ACC1 pathway
Cell Reports Medicine, Vol. 5, Núm. 2
2023
-
A Novel Mouse Model of Combined Hepatocellular-Cholangiocarcinoma Induced by Diethylnitrosamine and Loss of Ppp2r5d
Cancers, Vol. 15, Núm. 16
-
Advancing with cancer immunotherapeutics: CD29+ regulatory T cell antagonism
Gut
-
Expression of Cyclin E1 in hepatic stellate cells is critical for the induction and progression of liver fibrosis and hepatocellular carcinoma in mice
Cell Death and Disease, Vol. 14, Núm. 8
-
Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress
Frontiers in immunology, Vol. 14, pp. 1185517
-
Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming
Journal of Hepatology, Vol. 79, Núm. 3, pp. 728-740
-
JNKs protect from cholestatic liver disease progression by modulating Apelin signalling
JHEP Reports, Vol. 5, Núm. 11
-
Lack of Cyclin E1 in hepatocytes aggravates ethanol-induced liver injury and hepatic steatosis in experimental murine model of acute and chronic alcohol-associated liver disease
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1869, Núm. 4
-
Mouse Models for Hepatic Stellate Cell Activation and Liver Fibrosis Initiation
Methods in molecular biology (Clifton, N.J.), Vol. 2669, pp. 177-191
-
Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis
Cell death & disease, Vol. 14, Núm. 8, pp. 514